NantOmics

NantOmics, LLC
Limited liability company
Industry Biotechnology, molecular diagnostics

NantOmics is a biotechnology company based in Culver City, California, which provides molecular diagnostic products for personalized cancer treatment. It is part of the Nantworks network, a corporation consisting of different startups in the medical and health industry.[1]

History

NantOmics was founded in 2013 by billionaire Patrick Soon-Shiong. In 2015 NantOmics bought the cancer diagnostics company OncoPlex Dx.[2] In 2017 the company acquired the consumer genomics startup Genos.[3]

In 2016 the company's revenue was about $58.3 million with a net loss of about $72.00 million.[4] As of 2017, the company is classified as a unicorn startup with an estimated value of over $1 billion.

Products

GPS Cancer involves sequencing of the genome and RNA of tumor cells in comparison to normal cells from the same individual in order to develop personalized treatments.[5]

About 327,000 cancer patients particated in a GPS cancer pilot project in 2017.[6]

References

  1. ↑ "NantOmics, LLC: Private Company Information - Bloomberg". www.bloomberg.com. Retrieved 2018-03-30.
  2. ↑ "NantOmics Acquires OncoPlex Diagnostics, an Accredited Proteomics Diagnostic Laboratory". Retrieved 2018-03-30.
  3. ↑ "Bio-IT World". www.bio-itworld.com. Retrieved 2018-03-30.
  4. ↑ "NantHealth files for $92 million IPO". MobiHealthNews. 2016-05-09. Retrieved 2018-03-30.
  5. ↑ "GPS Cancer Overview". GPS Cancer. Retrieved 2018-03-30.
  6. ↑ "NantHealth Reports 16% Increase in 2017 First Quarter Total Net Revenue; SaaS Revenue Rose 11% and GPS Adoption Continues to Climb". Retrieved 2018-03-30.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.